SCHEMBL14769546

SCHEMBL14769546

CC#Cc1nn(C)c2nc(Cl)cc(C(=O)O)c12

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ S1PR2 O95136 6/20 0.34
▸ PPARA Q07869 5/20 0.33
▸ PPARG P37231 1/20 0.33
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ S1PR5 Q9H228 2/20 0.32
▸ MAPT P10636 1/20 0.32
▸ GLP1R P43220 1/20 0.32
▸ FFAR4 Q5NUL3 1/20 0.32
▸ GPR119 Q8TDV5 1/20 0.32
▸ KDM4E B2RXH2 4/20 0.32
▸ FTO Q9C0B1 1/20 0.32
▸ ALDH1A1 P00352 5/20 0.32
▸ HPGD P15428 2/20 0.32
▸ HTT P42858 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14752623 0.80 S1PR2 (0.47) S1PR2MEN1KMT2AS1PR5MAPT
SCHEMBL14769544 0.79 S1PR2 (0.36) S1PR2PPARAPPARGMEN1KMT2A
SCHEMBL14769540 0.68 S1PR2 (0.36) S1PR2MEN1KMT2AS1PR5MAPT
SCHEMBL10254524 0.66 TSHR (0.41) PPARAPPARGMEN1KMT2AMAPT
SCHEMBL1694840 0.66 NR3C1 (0.41) PPARAPPARGMEN1KMT2AMAPT
SCHEMBL3717109 0.65 TDP1 (0.48) PPARAPPARGMAPTKDM4EALDH1A1
SCHEMBL14769545 0.65 S1PR2 (0.34) S1PR2MEN1KMT2AS1PR5MAPT
SCHEMBL14919744 0.64 CFTR (0.46) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL14752625 0.64 ALDH1A1 (0.46) S1PR2MEN1KMT2AMAPTKDM4E
SCHEMBL31347270 0.64 KDM4E (0.40) PPARAPPARGMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8846712-B2 6-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors SANOFI (FR) 2014-09-30 — — US disclosed
US-20130065894-A1 6-(4-HYDROXY-PHENYL)-3-STYRYL-1H-PYRAZOLO[3,4-b]PYRIDINE-4-CARBOXYLIC ACID AMIDE DERIVATIVES AS KINASE INHIBITORS SANOFI (FR) 2013-03-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130065894-A1 6-(4-HYDROXY-PHENYL)-3-STYRYL-1H-PYRAZOLO[3,4-b]PYRIDINE-4-CARBOXYLIC ACID AMIDE DERIVATIVES AS KINASE INHIBITORS MAP3K1, MAP4K2, MAP3K6 S1PR2 761/4885PPARA 1289/4885PPARG 1005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback